| How are healthcare systems and health plans directly investing in innovative companies in Europe? |
Tsafrir Kolatt is the CEO of Fertigo Medical, a company devoted to increase the success rate in In-vitro Fertilization procedures. Prior to that Kolatt has led a few medical device and AI private and public companies (CEO, EVP, VP R&D) that developed new, successful devices for both therapy and diagnosis. Dr. Kolatt got his Ph.D. in theoretical astrophysics from the Hebrew University and was a post-doc researcher in Harvard University and UCSC. Kolatt published a few books, dozens of scientific papers and many popular articles. He won numerous scholarships and prizes for research, innovative product development, poetry and play-writing. He also serves as the chairperson of IYAR – the Israeli Institute for Advanced Research.